Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am a no based on transparency and accountability on a true up. As far as the recent news it is typical we need to spend collective time trying to figure out what they are stating.
Right. I reread the second to last paragraph.
So looks pretty good. They do all the trials and if approved we sell the product and pay them 4%. Not bad if I read it correctly.
Thanks. Looks like colorectal and ovarian cancer.
If they sell product NWBO gets 4% of sales. Like a licensing fee. It would be nice to know what 3 cancer indications they are going after in the phase II trials.
I am sure they have the votes so how you voted probably has no meaning. They called you because they need a certain amount of shareholders voting.
Her salary. When she starts meeting implied timelines, goals and moves the share price in a positive direction she would be entitled to a bonus. Also, the thought she is personally writing patents is ridiculous. They have consultants for everything.
I believe there was spoofing. And I believe naked shorting happened years ago. I do not believe the naked shorting now. Our dilemma is from the type of constant finance conundrum made possible by management combined with the illegal spoofing a couple of years ago.
As far as LP and Les they do not give me confidence. I welcome a change that I have called for years ago. Even with approval which I expect to come. Tired of being lied to by omission.
If. I doubt it. But if you say so I will not argue the point. For many long years the talk of this board is LP will trap all the naked shorts. If she stepped down today she just might trap them.
3 years? More like a decade.
I disagree. A hostile takeover still has a poison pill. Shares you own will be upped to make it painful to the buyer. Giving an extremely large gift to the top two players makes it easier for them to take the entity private. That would be another lawsuit in the making. Also a large amount of shares to LG and LP lowers any eps when profits come along. That will lower your share price.
I am for bonuses but not this kind. If they get the votes or not, the judge probably will side with the plaintiff.
Interesting idea.
My guess is the new Director. Better than a deal with Streeterville. That is the vulture financing we got for years. A refreshing change. The only good thing I can say about management lately.
SOC is paid for by insurance. The patient’s and their families are reticent as well as the physicians. Right to try means the patient’s insurance will not pay. Faced with that situation how many families would put the money up? A combo trial is a different story. You would end up getting the vaccine with all expenses paid.
An accredited investor is retail. Not a fund or institution. Many here who bought in the open market can file they have the net worth.
In the same boat.
Recent retail sales are “C” share buyers. Plenty on this board have bought “C” shares. At higher prices than 46 cents. I do not mind giving them a vote for a bonus but let them execute, provide accountability and transparency. I have not seen much or any of this for many years. Going back to the rift with Woodford and the hold on screening. That is a decade long.
Advent isn’t the jewel. NWBO owns the patents for the process and owns Flaskworks. As a part of lacking transparency, shareholders do not know what % Advent will make during commercial production. Just one of the many areas this management team fails inform.
I am a believer in the technology and happy to see it is finally coming to fruition. But, I have voted against outrageous bonuses without transparency and accountability. The lawsuit has merit. Management doesn’t have the right to say we deserve 20% of the company. Each year they were entitled to a certain bonus based on performance. I cannot say their execution has been well thought out over the years. So, again I am a “NO” even if it is an exercise in futility.
I am a bit more sanguine about the sale of common. It could have easily been a loan. It brings some analysis and possible investment recognition.
I wonder how much the new director had in this decision because it is a better direction than the Big Boob Show.
I would bet they could have procured a loan for that much. Instead this company took equity. The added benefit is they do actual analysis for the markets. It benefits NWBO to start getting coverage. With this act we may start to finally see participation at investment conferences. Wouldn’t that be a change?
They didn’t sell C shares. They sold common shares. They just negotiated the deal. It could have been at 20 cents if management agreed.
“we do not know what
they have endured, its been a dog fight all the way and to slap them in the face at this point is nuts, just my opinion.”
That is one reason why it is a “NO”. Zero transparency.
They know about NWBO. They helped fester the court cases over a decade ago.
Speaking of C preferred. If management wants a true-up here is their chance. You can buy 3 million c shares and have 75 million common when converted. It will get them partially there to 300 to 400 million that they think they deserve.
Tired of the excuses and broken promises and lack of transparency. Let them start buying close to market prices. It is because of them and malicious traders why the share price has been crushed. Take some responsibility.
Issue another 300 million shares to officers and that is constant pain every earnings cycle.
And here is an example of an elongated timeframe. After data lock TLD could have been had within 3 months and they initially talked about weeks to perform this task. Instead they went for a journal article that took over a year. Because it took so long they botched the TLD rollout. There may have been another motive such as waiting for EDEN but shareholders were not informed. Not everything is a secret when you run a public company.
It is possible because the majority of shares had been controlled by insiders and shareholders who benefited from favorable terms. It neglected the multitude of smaller shareholders. Option or share compensation have not come close to reflecting shareholder wellbeing. I have voted against their shares for some time. Mostly because of promises implied and if fulfilled they were done so with very elongated timeframes. That is how. I think he wins the case and when the management starts meeting shareholder expectations I will then vote for bonuses. Reasonable bonuses. They need to run the company as a public company. Not a personal piggy bank.
“How is this capitalism, and not a command economy, when a judge by fiat can overrule a vote the supermajority made twice already? “
Who do you think the majority of remaining C shares are for? Management.
But I am impressed you actually think they should perform better prior to saying yes to their bonuses.
That was a shock to my system.
You should know this answer now and a rough schedule when they intend to be making 15000 vaccines.
I am always hopeful for a proper ASM with analysts and robust Q&A. Never happens. Really hopeful they meet the promises. That is definitely a no go.
See if this new Director (Thermo?) can shake the tree but I doubt he can. Too many comfortable managers.
Sure we get it. I get it but we should know what % of revenue will got to Advent with commercial product. We should all know that by now. We should also have a proper breakdown on what we are currently funding.
“I too am hopeful of some exciting news to be shared at the ASM.”
How many ASM calls with NWBO have you thought the exact same things prior? They have gone to zero investment conferences and provided no $ outlook ( optimistic to pessimistic) in the past. This ASM will be no different. Just more of no accountability.
Following the ASM the effect on the share price will be as tepid as the Big Biz Bounce. She will talk and say nothing at the same time. Shareholders deserve better than just a thanks for your support.
What you say is true. Unfortunately, management’s inability to predict and get out in front of a situation allows for malicious forces to form the narrative. Been going on for years. Their communication has been a travesty.
I know you will answer back in their defense but I am done for the day. Back to waiting for a better run company and real news.
Sorry to say that management has promised much and not delivered for over a decade. All while communicating poorly. Once again submit your written questions. Not a viable option when she can pick and choose what question(s) to answer. One year she answered one question about when TLD would be given. They managed to notch that timeline up. When they tie bonuses to share price and promises made then I will vote for their options. A year and 1/2 ago partnerships were implied as well as all RA submissions. That included with quiet, no proper Q&A with accredited analysts, and Les on the Big Biz Bomb I am still a “NO” on their bonuses. Perform at a reasonable clip and I will change my mind. I was down on management prior to but following that ridiculous May 10 surprise they completely lost my confidence. Just waiting for a change in operations or management and certainly not voting for bonuses.
Why! Why! Why! Do you continue with CRL? The Sawston plant has storage for 3 million doses and that is roughly 340K patients. What you state below makes zero sense.
“I agree that we'll be paying CRL a decent amount for manufacturing and cryopresrvation, and that they stand to benefit finanially very well and couldl eventually probably do more of the work of manufacturing in the world than NWBO's one Sawston's plant. “
Thanks for making that clear. They should still not be doing Big Biz and start proper quarterly calls.
I always expect more from them but with multiple IR people they just cannot get it together. So they send out Les. When will this guy finally leave the building? It is getting very old.
Never Cure knows how to do it. And they know how to score $. Still on hold with our clowns.
Always thought this. It has been a difficult decade to witness. Looking forward to a change in stock direction and company performance.